EP1251863A4 - 22 proteines humaines secretees - Google Patents

22 proteines humaines secretees

Info

Publication number
EP1251863A4
EP1251863A4 EP01910340A EP01910340A EP1251863A4 EP 1251863 A4 EP1251863 A4 EP 1251863A4 EP 01910340 A EP01910340 A EP 01910340A EP 01910340 A EP01910340 A EP 01910340A EP 1251863 A4 EP1251863 A4 EP 1251863A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01910340A
Other languages
German (de)
English (en)
Other versions
EP1251863A1 (fr
Inventor
Craig A Rosen
George A Komatsoulis
Kevin P Baker
Charles E Birse
Daniel R Soppet
Henrik S Olsen
Paul A Moore
Ping Wei
Reinhard Ebner
D Roxanne Duan
Yanggu Shi
Gil H Choi
Michele Fiscella
Jian Ni
Steven M Ruben
Steven C Barash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1251863A1 publication Critical patent/EP1251863A1/fr
Publication of EP1251863A4 publication Critical patent/EP1251863A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
EP01910340A 2000-01-31 2001-01-17 22 proteines humaines secretees Withdrawn EP1251863A4 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US17906500P 2000-01-31 2000-01-31
US179065P 2000-01-31
US18062800P 2000-02-04 2000-02-04
US180628P 2000-02-04
US22627900P 2000-08-18 2000-08-18
US226279P 2000-08-18
US25198800P 2000-12-05 2000-12-05
US251988P 2000-12-05
US25967801P 2001-01-05 2001-01-05
US259678P 2001-01-05
PCT/US2001/001434 WO2001054708A1 (fr) 2000-01-31 2001-01-17 22 proteines humaines secretees

Publications (2)

Publication Number Publication Date
EP1251863A1 EP1251863A1 (fr) 2002-10-30
EP1251863A4 true EP1251863A4 (fr) 2005-03-02

Family

ID=27539005

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01910340A Withdrawn EP1251863A4 (fr) 2000-01-31 2001-01-17 22 proteines humaines secretees

Country Status (4)

Country Link
EP (1) EP1251863A4 (fr)
AU (1) AU2001237958A1 (fr)
CA (1) CA2396719A1 (fr)
WO (1) WO2001054708A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030149237A1 (en) * 2000-06-27 2003-08-07 Corine Vernet Novel polynucleotides and polypeptides encoded thereby
US7981420B2 (en) * 2000-12-22 2011-07-19 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
JP3910536B2 (ja) * 2000-12-28 2007-04-25 塩野義製薬株式会社 新規ポリペプチドおよびそのｄｎａ
US7125663B2 (en) 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
JP2003245084A (ja) 2001-12-20 2003-09-02 Morinaga Milk Ind Co Ltd 脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
US7319138B2 (en) 2002-04-18 2008-01-15 The General Hospital Corporation Human DRG11-Responsive Axonal Guidance and Outgrowth of Neurite (DRAGON) proteins and variants thereof
WO2004020465A2 (fr) * 2002-09-02 2004-03-11 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Proteines intervenant dans la regulation de l'homeostasie energetique
AU2015242979B2 (en) * 2002-11-22 2016-12-01 Ganymed Pharmaceuticals Ag Genetic products differentially expressed in tumors and the use thereof
DE10254601A1 (de) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
AU2013260709C1 (en) * 2004-05-18 2016-09-08 Astellas Pharma Inc. Genetic products differentially expressed in tumors and the use thereof
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1858541B1 (fr) 2005-02-16 2012-07-25 The General Hospital Corporation Utilisation d'antagonistes du bmp pour reguler le metabolisme du fer dependant de l'hepcidine et traiter le déficit en fer
CA2624562A1 (fr) 2005-09-30 2007-04-12 Abbott Gmbh & Co. Kg Domaines de liaison de proteines de la famille proteinique des molecules de guidage repulsif (rgm), fragments fonctionnels de ces domaines et leur utilisation
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
US8895002B2 (en) 2007-04-09 2014-11-25 The General Hospital Corporation Hemojuvelin fusion proteins and uses thereof
US8962803B2 (en) 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
CA2780069C (fr) 2009-12-08 2018-07-17 Abbott Gmbh & Co. Kg Anticorps monoclonaux contre la proteine rgm a destines a etre utilises dans le traitement de la degenerescence de la couche de fibres nerveuses retiniennes
NZ625403A (en) 2012-01-27 2016-03-31 Abbvie Inc Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer
WO2013174404A1 (fr) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
KR102381936B1 (ko) 2012-11-13 2022-04-01 비온테크 에스이 클라우딘 발현 암 질환의 치료제
WO2014127785A1 (fr) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
WO2014146672A1 (fr) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Thérapie comprenant des anticorps dirigés contre cldn 18.2 pour le traitement du cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012708A2 (fr) * 1998-09-01 2000-03-09 Genentech, Inc. Nouveaux pro-polypeptides et sequences correspondantes
WO2000015659A2 (fr) * 1998-09-16 2000-03-23 Zymogenetics, Inc. Polypeptide stomacal zsig28

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012708A2 (fr) * 1998-09-01 2000-03-09 Genentech, Inc. Nouveaux pro-polypeptides et sequences correspondantes
WO2000015659A2 (fr) * 1998-09-16 2000-03-23 Zymogenetics, Inc. Polypeptide stomacal zsig28

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 19 January 2000 (2000-01-19), "Homo sapiens Claudin-18 mRNA, compete cds", XP002296100, Database accession no. AF221069 *
MORITA K ET AL: "CLAUDIN MULTIGENE FAMILY ENCODING FOUR-TRANSMEMBRANE DOMAIN PROTEIN COMPONENTS OF TIGHT JUNCTION STRANDS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 96, January 1999 (1999-01-01), pages 511 - 516, XP002942697, ISSN: 0027-8424 *
See also references of WO0154708A1 *

Also Published As

Publication number Publication date
WO2001054708A1 (fr) 2001-08-02
AU2001237958A1 (en) 2001-08-07
EP1251863A1 (fr) 2002-10-30
CA2396719A1 (fr) 2001-08-02

Similar Documents

Publication Publication Date Title
EP1181390A4 (fr) 27 proteines humaines secretees
EP1251863A4 (fr) 22 proteines humaines secretees
EP1175438A4 (fr) Soixante-deux prot ines humaines s cr t es
EP1175439A4 (fr) 49 proteines humaines secretees
EP1165827A4 (fr) 45 proteines humaines secretees
EP1159284A4 (fr) 33 proteines humaines secretees
EP1254242A4 (fr) 17 proteines secretees humaines
EP1368468A4 (fr) 83 proteines humaines secretes
EP1173477A4 (fr) 49 proteines humaines secretees
EP1165602A4 (fr) 49 proteines secretees par un etre humain
EP1171460A4 (fr) 48 proteines secretees humaines
EP1144614A4 (fr) Proteines humaines secretees (33)
EP1169332A4 (fr) Proteines humaines secretees (49)
EP1370651A4 (fr) 70 proteines humaines secretees
EP1317471A4 (fr) 21 proteines humaines secretees
EP1185285A4 (fr) 49 proteines secretees humaines
EP1322657A4 (fr) Proteines secretees humaines 22
EP1317472A4 (fr) 17 proteines humaines secretees
EP1165123A4 (fr) 48 proteines humaines secretees
EP1171626A4 (fr) Cinquante proteines humaines secretees
EP1181303A4 (fr) 50 proteines humaines secretees
EP1159287A4 (fr) Proteines humaines secretees (50)
EP1165591A4 (fr) 47 proteines humaines secretees
EP1322659A4 (fr) 21 proteines humaines secretees
EP1404807A4 (fr) 20 proteines humaines secretees

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020812

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/705 A

Ipc: 7A 61K 38/16 B

Ipc: 7C 12N 9/00 B

Ipc: 7A 61K 38/43 B

Ipc: 7G 01N 33/68 B

Ipc: 7G 01N 33/53 B

Ipc: 7A 61K 39/395 B

Ipc: 7A 61K 48/00 B

Ipc: 7C 12N 15/12 B

Ipc: 7C 07K 14/47 B

Ipc: 7A 61K 31/713 B

Ipc: 7C 12N 15/52 B

Ipc: 7C 12Q 1/68 B

Ipc: 7A 61K 31/7088 B

A4 Supplementary search report drawn up and despatched

Effective date: 20050117

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060303